1. Improved patient‐reported outcomes with iGlarLixi versus premix BIAsp 30 in people with type 2 diabetes in the SoliMix trial. Issue 12 (23rd August 2022) Authors: Polonsky, William H.; Giorgino, Francesco; Rosenstock, Julio; Whitmire, Katherine; Lew, Elisheva; Coudert, Mathieu; Alvarez, Agustina; Nicholls, Charlie; McCrimmon, Rory J. Journal: Diabetes, obesity & metabolism Issue: Volume 24:Issue 12(2022) Page Start: 2364 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗